Loading...

Hypercalcemia and hypercalciuria during denosumab treatment in children with osteogenesis imperfecta type VI

Children with osteogenesis imperfecta (OI) type VI often have high fracture rates despite the current standard treatment with bisphosphonates. Subcutaneous injections of denosumab have been proposed as an alternative treatment approach, but safety data on denosumab in children are limited. Here we d...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Musculoskelet Neuronal Interact
Main Authors: Trejo, Pamela, Rauch, Frank, Ward, Leanne
Format: Artigo
Sprog:Inglês
Udgivet: International Society of Musculoskeletal and Neuronal Interactions 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5881132/
https://ncbi.nlm.nih.gov/pubmed/29504582
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!